Caribou Biosciences, Inc.
NASDAQ:CRBU
1.8 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.024 | 3.464 | 2.429 | 3.558 | 23.662 | 3.755 | 3.502 | 3.692 | 3.303 | 4.192 | 2.664 | 2.559 | 3.977 | 1.476 | 1.586 | 0.984 | 1.198 | 8.478 | 1.701 |
| Cost of Revenue
| 0 | 0.856 | 0.71 | 1.974 | 2.106 | 1.126 | 1.104 | 0.903 | 1.072 | 0.858 | 0.808 | 0.273 | 15.833 | 12.327 | 10.165 | 12.024 | 6.18 | 7.58 | 8.641 |
| Gross Profit
| 2.024 | 2.608 | 1.719 | 1.584 | 21.556 | 2.629 | 2.398 | 2.789 | 2.231 | 3.334 | 1.856 | 2.286 | -11.856 | -10.851 | -8.579 | -11.04 | -4.982 | 0.898 | -6.94 |
| Gross Profit Ratio
| 1 | 0.753 | 0.708 | 0.445 | 0.911 | 0.7 | 0.685 | 0.755 | 0.675 | 0.795 | 0.697 | 0.893 | -2.981 | -7.352 | -5.409 | -11.22 | -4.159 | 0.106 | -4.08 |
| Reseach & Development Expenses
| 30.421 | 35.48 | 33.788 | 31.279 | 28.584 | 26.503 | 25.709 | 25.736 | 19.991 | 22.579 | 13.924 | 15.111 | 15.833 | 12.327 | 10.165 | 12.024 | 6.18 | 7.58 | 8.641 |
| General & Administrative Expenses
| 9.841 | 11.485 | 14.643 | 9.721 | 9.711 | 10.12 | 8.909 | 8.534 | 9.849 | 10.044 | 9.593 | 7.853 | 6.76 | 5.113 | 4.596 | 4.173 | 3.247 | 3.153 | 3.489 |
| Selling & Marketing Expenses
| 0 | -0.856 | 0 | -1.974 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.841 | 10.629 | 14.643 | 7.747 | 9.711 | 10.12 | 8.909 | 8.534 | 9.849 | 10.044 | 9.593 | 7.853 | 6.76 | 5.113 | 4.596 | 4.173 | 3.247 | 3.153 | 3.489 |
| Other Expenses
| 0 | 5.906 | 4.768 | 3.139 | 4.635 | 3.327 | 3.087 | 3.719 | -0.141 | 1.75 | 1.853 | 2.171 | -2.38 | 0.025 | 0.017 | 0.083 | 0.085 | 0.327 | 0.021 |
| Operating Expenses
| 40.262 | 46.109 | 48.431 | 39.026 | 38.295 | 36.623 | 34.618 | 34.27 | 29.84 | 32.623 | 23.517 | 22.964 | 22.593 | 17.44 | 14.761 | 16.197 | 9.427 | 10.733 | 12.13 |
| Operating Income
| -38.238 | -43.501 | -46.002 | -37.442 | -14.633 | -32.868 | -31.116 | -30.578 | -26.537 | -28.431 | -20.853 | -20.405 | -18.616 | -15.964 | -13.175 | -15.213 | -8.229 | -2.255 | -10.429 |
| Operating Income Ratio
| -18.892 | -12.558 | -18.939 | -10.523 | -0.618 | -8.753 | -8.885 | -8.282 | -8.034 | -6.782 | -7.828 | -7.974 | -4.681 | -10.816 | -8.307 | -15.46 | -6.869 | -0.266 | -6.131 |
| Total Other Income Expenses Net
| 3.554 | 5.804 | 4.768 | 3.13 | 4.631 | 3.349 | 3.072 | 3.659 | -0.11 | 1.734 | 1.765 | 2.247 | -2.358 | 1.653 | 0.016 | 0.156 | 0.083 | 0.333 | -0.573 |
| Income Before Tax
| -34.684 | -37.697 | -41.234 | -34.312 | -10.002 | -29.519 | -28.044 | -26.919 | -26.647 | -26.697 | -19.088 | -18.158 | -20.974 | -14.311 | -13.159 | -15.057 | -8.146 | -1.922 | -11.002 |
| Income Before Tax Ratio
| -17.136 | -10.883 | -16.976 | -9.644 | -0.423 | -7.861 | -8.008 | -7.291 | -8.068 | -6.369 | -7.165 | -7.096 | -5.274 | -9.696 | -8.297 | -15.302 | -6.8 | -0.227 | -6.468 |
| Income Tax Expense
| 0 | 0 | -0.71 | 0.193 | -1.579 | -0.639 | -3.057 | 0.07 | 0.11 | -1.734 | -1.765 | 0.321 | -2.38 | 0.027 | 0.022 | -0.354 | -0.213 | -0.05 | -1.202 |
| Net Income
| -34.684 | -37.697 | -41.234 | -34.505 | -10.002 | -29.519 | -24.987 | -26.989 | -26.757 | -24.963 | -17.323 | -18.479 | -20.974 | -14.311 | -13.159 | -14.703 | -7.933 | -1.872 | -9.8 |
| Net Income Ratio
| -17.136 | -10.883 | -16.976 | -9.698 | -0.423 | -7.861 | -7.135 | -7.31 | -8.101 | -5.955 | -6.503 | -7.221 | -5.274 | -9.696 | -8.297 | -14.942 | -6.622 | -0.221 | -5.761 |
| EPS
| -0.38 | -0.42 | -0.46 | -0.39 | -0.12 | -0.48 | -0.41 | -0.44 | -0.44 | -0.41 | -0.29 | -0.31 | -0.46 | -0.26 | -0.48 | -0.53 | -0.29 | -0.068 | -0.35 |
| EPS Diluted
| -0.38 | -0.42 | -0.46 | -0.39 | -0.12 | -0.48 | -0.41 | -0.44 | -0.44 | -0.41 | -0.29 | -0.31 | -0.46 | -0.26 | -0.48 | -0.53 | -0.29 | -0.068 | -0.35 |
| EBITDA
| -38.238 | -42.645 | -45.292 | -36.702 | -13.054 | -32.251 | -30.527 | -32.645 | -26.087 | -28.073 | -20.545 | -17.885 | -18.356 | -15.734 | -12.954 | -14.831 | -7.914 | -1.689 | -10.773 |
| EBITDA Ratio
| -18.892 | -12.311 | -18.939 | -9.969 | -0.618 | -8.759 | -8.713 | -8.266 | -7.907 | -6.693 | -7.679 | -7.096 | -5.208 | -10.612 | -8.154 | -15.072 | -6.606 | -0.199 | -5.902 |